Literature DB >> 16195056

A brief motivational intervention for treatment-refusing OCD patients.

Nicholas Maltby1, David F Tolin.   

Abstract

Cognitive behavioral therapy involving exposure and response prevention (ERP) is the psychosocial treatment of choice for obsessive-compulsive disorder (OCD). Despite this, ERP is not widely used by mental health practitioners, and so dissemination of ERP and other empirically supported treatment (ESTs) has become a priority. Even so, utilization of ESTs such as ERP remains below 50% even among therapists who self-identify as having a cognitive behavioral orientation. Barriers to the acceptance of ERP include practical obstacles such as lack of training and the cost of treatment, but also patient variables such as treatment refusal. It has been estimated that approximately 25% of OCD patients refuse ERP. This paper describes a brief, 4-session readiness intervention (RI) designed to decrease ERP refusal among patients with OCD. In this study, 12 patients with OCD who had refused ERP were randomized to RI or wait-list (WL). 86% of participants in the RI condition and 20% of participants in WL condition agreed to begin ERP following the 4-week period. ERP following RI, but not WL, was associated with a decrease in OCD symptoms comparable to that observed in OCD patients who did not refuse ERP. However, ERP following RI was associated with a high drop-out rate (50%), a figure that exceeds that typically seen in OCD treatment studies. Techniques to reduce drop-out as well as directions for future research are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16195056     DOI: 10.1080/16506070510043741

Source DB:  PubMed          Journal:  Cogn Behav Ther        ISSN: 1650-6073


  12 in total

1.  Effect of anxiety on treatment presentation and outcome: results from the Marijuana Treatment Project.

Authors:  Julia D Buckner; Kathleen M Carroll
Journal:  Psychiatry Res       Date:  2010-08-15       Impact factor: 3.222

2.  Obsessive-compulsive disorder: Evidence-based treatments and future directions for research.

Authors:  Caleb W Lack
Journal:  World J Psychiatry       Date:  2012-12-22

3.  Motivational Interviewing as an Adjunct to Cognitive Behavior Therapy for Anxiety Disorders: A Critical Review of the Literature.

Authors:  Cameron L Randall; Daniel W McNeil
Journal:  Cogn Behav Pract       Date:  2017-08

4.  Patient utilization of cognitive-behavioral therapy for OCD.

Authors:  Maria C Mancebo; Jane L Eisen; Nicholas J Sibrava; Ingrid R Dyck; Steven A Rasmussen
Journal:  Behav Ther       Date:  2011-03-05

5.  Overcoming barriers to disseminating exposure therapies for anxiety disorders: a pilot randomized controlled trial of training methods.

Authors:  Melanie S Harned; Linda A Dimeff; Eric A Woodcock; Julie M Skutch
Journal:  J Anxiety Disord       Date:  2011-03

6.  An open trial of cognitive-behavioral therapy for compulsive hoarding.

Authors:  David F Tolin; Randy O Frost; Gail Steketee
Journal:  Behav Res Ther       Date:  2007-01-16

7.  Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder.

Authors:  Helen Blair Simpson; Allan M Zuckoff; Michael J Maher; Jessica R Page; Martin E Franklin; Edna B Foa; Andrew B Schmidt; Yuanjia Wang
Journal:  Behav Res Ther       Date:  2010-06-01

8.  Pretreatment Intervention Increases Treatment Outcomes for Patients with Anxiety Disorders.

Authors:  Julia D Buckner; Kiara R Cromer; Katherine A Merrill; Michael A Mallott; Norman B Schmidt; Cristina Lopez; Jill M Holm-Denoma; Thomas E Joiner
Journal:  Cognit Ther Res       Date:  2009

9.  Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study.

Authors:  Lisa J Merlo; Eric A Storch; Heather D Lehmkuhl; Marni L Jacob; Tanya K Murphy; Wayne K Goodman; Gary R Geffken
Journal:  Cogn Behav Ther       Date:  2010

10.  The development of performance-monitoring function in the posterior medial frontal cortex.

Authors:  Kate Dimond Fitzgerald; Suzanne C Perkins; Mike Angstadt; Timothy Johnson; Emily R Stern; Robert C Welsh; Stephan F Taylor
Journal:  Neuroimage       Date:  2009-11-10       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.